Mustang Bio (MBIO) Enterprise Value (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Enterprise Value of -$16.3 million for Q1 2026, down 14.24% year-over-year from -$19.0 million in Q1 2025, and up 5.84% quarter-over-quarter from -$17.3 million in Q4 2025.
Mustang Bio (MBIO) Enterprise Value (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Enterprise Value for 11 consecutive years, with -$16.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 14.24% year-over-year to -$16.3 million; the TTM figure through Mar 2026 stood at -$16.3 million (down 14.24% YoY), while the FY2025 annual figure was -$17.3 million, down 152.46% from the prior year.
- Enterprise Value advanced to -$16.3 million in Q1 2026 per MBIO's latest filing, from -$17.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.3 million in Q1 2024 and bottomed at -$122.2 million in Q1 2022.
- Historically, Enterprise Value has averaged -$34.2 million across 5 years, with a median of -$15.4 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 7465.6% — and 2024, when it surged 97.7%.
- Mustang Bio's Enterprise Value stood at -$75.7 million in 2022, then soared by 91.76% to -$6.2 million in 2023, then decreased by 9.7% to -$6.8 million in 2024, then slumped by 152.46% to -$17.3 million in 2025, then rose by 5.84% to -$16.3 million in 2026.
- Business Quant data shows MBIO's Enterprise Value at -$16.3 million in Q1 2026, -$17.3 million in Q4 2025, and -$19.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 2.12 Bn |
| 10 | Mustang Bio | 3.86 Mn | 3.86 Mn | - | -15.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.20 Mn |
| Mar 31, 2026 | -16.26 Mn |
| Dec 31, 2025 | -17.27 Mn |
| Sep 30, 2025 | -18.98 Mn |
| Jun 30, 2025 | -12.66 Mn |
| Mar 31, 2025 | -14.23 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Sep 30, 2024 | -3.53 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | -1.34 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -9.56 Mn |
| Jun 30, 2023 | -15.39 Mn |
| Mar 31, 2023 | -58.10 Mn |
| Dec 31, 2022 | -75.66 Mn |
| Sep 30, 2022 | -91.36 Mn |
| Jun 30, 2022 | -107.37 Mn |
| Mar 31, 2022 | -122.22 Mn |
| Dec 31, 2021 | -1.00 Mn |
| Sep 30, 2021 | -120.88 Mn |